HUP9901208A2 - (R)-5-Bróm-n-(1-etil-4-metil-hexahidro-1H-1,4-diazepin-6-il)-2-metoxi-6-(metil-amino)-3-piridin-karboxamid, eljárás előállítására és ezt a vegyületet tartalmazó gyógyászati készítmény - Google Patents

(R)-5-Bróm-n-(1-etil-4-metil-hexahidro-1H-1,4-diazepin-6-il)-2-metoxi-6-(metil-amino)-3-piridin-karboxamid, eljárás előállítására és ezt a vegyületet tartalmazó gyógyászati készítmény

Info

Publication number
HUP9901208A2
HUP9901208A2 HU9901208A HUP9901208A HUP9901208A2 HU P9901208 A2 HUP9901208 A2 HU P9901208A2 HU 9901208 A HU9901208 A HU 9901208A HU P9901208 A HUP9901208 A HU P9901208A HU P9901208 A2 HUP9901208 A2 HU P9901208A2
Authority
HU
Hungary
Prior art keywords
same
methylhexahydro
diazepin
carboxamide
bromo
Prior art date
Application number
HU9901208A
Other languages
English (en)
Inventor
Hiroshi Harada
Yoshimi Hirokawa
Shiro Kato
Toshiya Morie
Naoyuki Yoshida
Original Assignee
Dainippon Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Pharmaceutical Co., Ltd. filed Critical Dainippon Pharmaceutical Co., Ltd.
Publication of HUP9901208A2 publication Critical patent/HUP9901208A2/hu
Publication of HUP9901208A3 publication Critical patent/HUP9901208A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/08—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)

Abstract

A találmány az (I) képletű vegyületre és ennek gyógyászatilagelfőgadható savaddíciós sóira vőnatkőzik. A találmány szerintivegyület kiváló antiemetikűs hatású pőtens szerőtőnin S3 és dőpamin D2receptőr antagőnista hatására tekintettel, így felhasználhatókülönböző megbetegedésekkel és hatóanyagők beadásával együttjárógasztrőintesztinális szimptómák kezelésére vagy megelőzésére. ŕ
HU9901208A 1995-07-28 1996-07-23 (r)-5-bromo-n-(1-ethyl-4-methylhexahydro-1h-1,4-diazepin-6-yl)-2-methoxy-6-methyl-amino-3-pyridine-carboxamide, process for producing the same and medicinal composition containing the same HUP9901208A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP07212495 1995-07-28
PCT/JP1996/002053 WO1997005129A1 (fr) 1995-07-28 1996-07-23 (r)-5-bromo-n-(1-ethyl-4-methylhexahydro-1h-1,4-diazepin-6-yl)-2-methoxy-6-methylamino-3-pyridine-carboxamide, son procede d'obtention et medicament le contenant

Publications (2)

Publication Number Publication Date
HUP9901208A2 true HUP9901208A2 (hu) 2000-04-28
HUP9901208A3 HUP9901208A3 (en) 2002-10-28

Family

ID=16623612

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9901208A HUP9901208A3 (en) 1995-07-28 1996-07-23 (r)-5-bromo-n-(1-ethyl-4-methylhexahydro-1h-1,4-diazepin-6-yl)-2-methoxy-6-methyl-amino-3-pyridine-carboxamide, process for producing the same and medicinal composition containing the same

Country Status (25)

Country Link
US (1) US5945415A (hu)
EP (1) EP0855397B1 (hu)
KR (1) KR19990028395A (hu)
CN (1) CN1096459C (hu)
AT (1) ATE201021T1 (hu)
AU (1) AU700635B2 (hu)
BR (1) BR9609691A (hu)
CA (1) CA2228056A1 (hu)
CZ (1) CZ290442B6 (hu)
DE (1) DE69612753T2 (hu)
DK (1) DK0855397T3 (hu)
ES (1) ES2156616T3 (hu)
GR (1) GR3036089T3 (hu)
HK (1) HK1018049A1 (hu)
HU (1) HUP9901208A3 (hu)
IL (1) IL122753A (hu)
MX (1) MX9800620A (hu)
NO (1) NO312964B1 (hu)
NZ (1) NZ312799A (hu)
PL (1) PL184073B1 (hu)
PT (1) PT855397E (hu)
RU (1) RU2156248C2 (hu)
SK (1) SK282044B6 (hu)
TR (1) TR199800165T1 (hu)
WO (1) WO1997005129A1 (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19650778C2 (de) * 1996-12-06 2001-01-04 Asta Medica Ag Verwendung von Dopaminrezeptor-Antagonisten in der palliativen Tumortherapie
GB0216027D0 (en) * 2002-07-10 2002-08-21 Arachnova Therapeutics Ltd New therapeutic use
US20040048874A1 (en) * 2001-05-22 2004-03-11 Bardsley Hazel Judith New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
ITBO20020198A1 (it) * 2002-04-12 2003-10-13 Univ Bologna Derivati 2 , 5 bis diammino 1 , 4 benzochenionici utili per il trattamento della malattia di alzheimer , metodo per la loro preparazione ed
BRPI0406749A (pt) * 2003-01-13 2005-12-20 Dynogen Pharmaceuticals Inc Métodos relacionados ao tratamento de distúrbios fincionais do intestino e composição farmacêutica
ATE359079T1 (de) * 2003-01-13 2007-05-15 Dynogen Pharmaceuticals Inc Verfahren zur behandlung von übelkeit, erbrechen, würgereiz oder jede kombination daraus
ATE365554T1 (de) * 2003-04-04 2007-07-15 Dynogen Pharmaceuticals Inc Methode zur behandlung von erkrankungen der unteren harnwege
US20060293309A1 (en) * 2005-03-28 2006-12-28 Dynogen Pharmaceuticals, Inc. Method of treating disorders and conditions using peripherally-restricted antagonists and inhibitors
AU2010231439A1 (en) 2009-03-31 2011-10-27 Zeria Pharmaceutical Co., Ltd. Method for manufacturing 1,5-benzodiazepine derivative
US9045460B2 (en) 2010-08-26 2015-06-02 Kowa Co., Ltd. Production method for isoquinoline derivatives and salts thereof
EP3102565B1 (en) * 2014-02-03 2019-01-02 Mylan Laboratories Ltd. Processes for the preparation of intermediates of raltegravir

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166341A (en) * 1988-07-29 1992-11-24 Dainippon Pharmaceutical Co., Ltd. 6-amino-1,4-hexahydro-1H-diazepine derivatives
US5017573A (en) * 1988-07-29 1991-05-21 Dainippon Pharmaceutical Co., Ltd. Indazole-3-carboxylic acid derivatives
JPH04210970A (ja) * 1990-01-26 1992-08-03 Dainippon Pharmaceut Co Ltd ベンズアミド誘導体及びその中間体
JPH03223265A (ja) * 1990-01-26 1991-10-02 Dainippon Pharmaceut Co Ltd 環状ジアミン誘導体
MX9206075A (es) * 1991-10-24 1993-04-01 Smithkline Beecham Plc Nuevos compuestos antagonistas del receptor 5-hidroxitriptamina y composiciones farmaceuticas que los contienen

Also Published As

Publication number Publication date
HUP9901208A3 (en) 2002-10-28
IL122753A0 (en) 1998-08-16
TR199800165T1 (xx) 1998-06-22
US5945415A (en) 1999-08-31
CN1096459C (zh) 2002-12-18
RU2156248C2 (ru) 2000-09-20
PL184073B1 (pl) 2002-08-30
CZ290442B6 (cs) 2002-07-17
PL324749A1 (en) 1998-06-08
NZ312799A (en) 1999-04-29
NO980333D0 (no) 1998-01-26
EP0855397A1 (en) 1998-07-29
KR19990028395A (ko) 1999-04-15
EP0855397A4 (en) 1998-12-02
CA2228056A1 (en) 1997-02-13
ES2156616T3 (es) 2001-07-01
WO1997005129A1 (fr) 1997-02-13
ATE201021T1 (de) 2001-05-15
NO312964B1 (no) 2002-07-22
MX9800620A (es) 1998-04-30
DE69612753D1 (de) 2001-06-13
SK9398A3 (en) 1998-08-05
HK1018049A1 (en) 1999-12-10
DK0855397T3 (da) 2001-06-25
AU6471796A (en) 1997-02-26
GR3036089T3 (en) 2001-09-28
CZ23098A3 (cs) 1998-06-17
AU700635B2 (en) 1999-01-07
PT855397E (pt) 2001-08-30
DE69612753T2 (de) 2005-07-07
NO980333L (no) 1998-03-23
BR9609691A (pt) 1999-03-23
EP0855397B1 (en) 2001-05-09
CN1192213A (zh) 1998-09-02
IL122753A (en) 2000-10-31
SK282044B6 (sk) 2001-10-08

Similar Documents

Publication Publication Date Title
BR9612291A (pt) Forma de dosagem sólida bioadesiva
HUP0302571A2 (hu) Szerves vegyületek keverékét tartalmazó gyógyszerkészítmény légúti betegségek kezelésére
IL149496A (en) Pharmaceutical compositions and their use in the treatment of the gastrointestinal tract
SE0104341D0 (sv) New use
HUP9901208A2 (hu) (R)-5-Bróm-n-(1-etil-4-metil-hexahidro-1H-1,4-diazepin-6-il)-2-metoxi-6-(metil-amino)-3-piridin-karboxamid, eljárás előállítására és ezt a vegyületet tartalmazó gyógyászati készítmény
NO304113B1 (no) Krystallinsk tiagabinhydrokloridmonohydrat, farmas°ytisk preparat som omfatter det, og anvendelse derav for fremstilling av et medikament
HUP0301390A2 (hu) Valzartánt tartalmazó orális gyógyászati készítmény
SE0102055D0 (sv) New Compounds
SE0102440D0 (sv) New compound
RO117760B1 (ro) Metodă pentru tratamentul unei afecţiuni de neurotransmisie serotoninergică defectivă
GR3019274T3 (en) Substituted 3-piperazinylalkyl-2,3-dihydro-4H-1,3-benzoxazine-4-ones, their preparation and their therapeutical use
BR9503572A (pt) Composto composiçao farmaceutica e método de tratamento ou prevençao de uma doença
HU9303000D0 (en) Aryl-morpholine-derivatives and pharmaceutical compositions containing it and process for production thereof
HUP0300863A2 (hu) N-(3,5-diklór-2-metoxi-fenil)-4-metoxi-3-(1-piperazinil)-benzolszulfonamid, eljárás elżállítására és a vegyületet tartalmazó gyógyszerkészítmény
HUP9900227A2 (hu) AII-receptor antagonisták új gyógyszerészeti felhasználása
NO175679C (no) Analogifremgangsmåte for fremstilling av en terapeutisk aktiv, substituert aminforbindelse
MY133508A (en) Polymorphs of a crystalline azobicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions
IL126795A (en) Pharmaceutical compositions for the treatment of substance abuse disorders comprising pyridyl- and pyrimidyl-piperazines
CA2409845A1 (en) Active substance combination containing a compound with an opioid effect and at least one further compound of formula i
KR950700063A (ko) 외상후 스트레스 치료제로서의 브로파로민(Brofaromine as an agent for treating post-traumatic stress)
EE200100193A (et) 3-(1H-imidasool-4-ülmetüül)-indaan-5-ol'i kasutamine intraspinaalselt, teekasiseselt või epiduraalselt manustatava ravimi tootmises
NO974197L (no) Fremgangsmåte til fremstilling av estere av anhydroecgonin
KR940002268A (ko) 21-클로로-프레그난 유도체
MX9205204A (es) Composicion farmaceutica que comprende compuestos antagonistas del receptor 5-hidroxitriptamina